First Personal Financial Services Sells 658 Shares of Colgate-Palmolive (NYSE:CL)

First Personal Financial Services lessened its holdings in Colgate-Palmolive (NYSE:CLFree Report) by 0.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 98,184 shares of the company’s stock after selling 658 shares during the quarter. Colgate-Palmolive accounts for approximately 1.9% of First Personal Financial Services’ investment portfolio, making the stock its 18th biggest holding. First Personal Financial Services’ holdings in Colgate-Palmolive were worth $7,826,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the business. Geode Capital Management LLC lifted its position in shares of Colgate-Palmolive by 0.6% in the first quarter. Geode Capital Management LLC now owns 17,457,294 shares of the company’s stock worth $1,309,583,000 after purchasing an additional 112,177 shares in the last quarter. Morgan Stanley raised its position in Colgate-Palmolive by 3.2% during the third quarter. Morgan Stanley now owns 16,815,987 shares of the company’s stock worth $1,195,785,000 after acquiring an additional 514,559 shares in the last quarter. Moneta Group Investment Advisors LLC raised its position in Colgate-Palmolive by 90,253.2% during the fourth quarter. Moneta Group Investment Advisors LLC now owns 15,974,451 shares of the company’s stock worth $1,258,627,000 after acquiring an additional 15,956,771 shares in the last quarter. Northern Trust Corp raised its position in Colgate-Palmolive by 0.5% during the first quarter. Northern Trust Corp now owns 10,470,409 shares of the company’s stock worth $793,971,000 after acquiring an additional 50,040 shares in the last quarter. Finally, Norges Bank bought a new stake in Colgate-Palmolive during the fourth quarter worth $644,715,000. Institutional investors own 80.41% of the company’s stock.

Analyst Ratings Changes

Several research firms have issued reports on CL. Morgan Stanley upped their price target on shares of Colgate-Palmolive from $85.00 to $93.00 and gave the stock an “overweight” rating in a research report on Monday, January 29th. Stifel Nicolaus upped their price target on shares of Colgate-Palmolive from $89.00 to $94.00 and gave the stock a “buy” rating in a research report on Wednesday. Evercore ISI upped their price target on shares of Colgate-Palmolive from $90.00 to $96.00 and gave the stock an “outperform” rating in a research report on Monday, April 8th. StockNews.com downgraded shares of Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a report on Tuesday, February 20th. Finally, Bank of America upgraded shares of Colgate-Palmolive from a “neutral” rating to a “buy” rating and set a $90.00 price objective on the stock in a report on Friday, December 15th. Three investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $88.56.

Check Out Our Latest Report on CL

Colgate-Palmolive Trading Down 0.2 %

CL stock opened at $85.82 on Friday. The company has a debt-to-equity ratio of 8.59, a quick ratio of 0.71 and a current ratio of 1.11. The company’s 50-day simple moving average is $86.83 and its 200 day simple moving average is $80.25. Colgate-Palmolive has a 52 week low of $67.62 and a 52 week high of $90.37. The company has a market capitalization of $70.54 billion, a PE ratio of 30.87, a price-to-earnings-growth ratio of 3.27 and a beta of 0.42.

Colgate-Palmolive (NYSE:CLGet Free Report) last released its quarterly earnings results on Friday, January 26th. The company reported $0.87 EPS for the quarter, beating the consensus estimate of $0.85 by $0.02. Colgate-Palmolive had a net margin of 11.82% and a return on equity of 509.75%. The business had revenue of $4.95 billion for the quarter, compared to the consensus estimate of $4.89 billion. During the same period in the prior year, the company posted $0.77 earnings per share. Colgate-Palmolive’s revenue was up 6.9% compared to the same quarter last year. As a group, sell-side analysts anticipate that Colgate-Palmolive will post 3.49 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Monday, April 22nd will be given a dividend of $0.50 per share. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date is Friday, April 19th. This represents a $2.00 annualized dividend and a yield of 2.33%. Colgate-Palmolive’s dividend payout ratio is currently 69.06%.

Insider Buying and Selling

In related news, CEO Noel R. Wallace sold 69,948 shares of the company’s stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $84.22, for a total transaction of $5,891,020.56. Following the completion of the sale, the chief executive officer now owns 286,881 shares of the company’s stock, valued at $24,161,117.82. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other news, CEO Noel R. Wallace sold 69,948 shares of the stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $84.22, for a total value of $5,891,020.56. Following the completion of the transaction, the chief executive officer now owns 286,881 shares of the company’s stock, valued at $24,161,117.82. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Noel R. Wallace sold 50,000 shares of the stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $83.15, for a total transaction of $4,157,500.00. Following the completion of the transaction, the chief executive officer now directly owns 274,179 shares of the company’s stock, valued at approximately $22,797,983.85. The disclosure for this sale can be found here. Insiders sold 232,371 shares of company stock valued at $19,505,099 over the last quarter. 0.34% of the stock is owned by company insiders.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Further Reading

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.